↓ Skip to main content

Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome

Overview of attention for article published in BMC Ophthalmology, April 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome
Published in
BMC Ophthalmology, April 2015
DOI 10.1186/s12886-015-0019-x
Pubmed ID
Authors

Gala Beykin, Michelle Grunin, Edward Averbukh, Eyal Banin, Yitzchak Hemo, Itay Chowers

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Student > Master 5 15%
Student > Doctoral Student 4 12%
Student > Bachelor 4 12%
Other 2 6%
Other 5 15%
Unknown 8 24%
Readers by discipline Count As %
Medicine and Dentistry 13 38%
Agricultural and Biological Sciences 6 18%
Unspecified 1 3%
Immunology and Microbiology 1 3%
Nursing and Health Professions 1 3%
Other 2 6%
Unknown 10 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 January 2016.
All research outputs
#17,700,438
of 25,837,817 outputs
Outputs from BMC Ophthalmology
#994
of 2,709 outputs
Outputs of similar age
#171,279
of 281,100 outputs
Outputs of similar age from BMC Ophthalmology
#14
of 31 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,709 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 281,100 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.